While immunosuppression mediated by CLL cells may abrogate CAR T-cell function, in the presence of strong, positive activation signals such as stimulation with an aAPC or addition of high-dose IL2, CAR T-cell effector functions remain intact. Here, IL2 is linked to B-cell chronic lymphocytic leukemia.